TOXICOLOGY
🇬🇧
In English
In English
Practice Known Questions
Stay up to date with your due questions
Complete 5 questions to enable practice
Exams
Exam: Test your skills
Test your skills in exam mode
Learn New Questions
Manual Mode [BETA]
Select your own question and answer types
Specific modes
Learn with flashcards
Complete the sentence
Listening & SpellingSpelling: Type what you hear
multiple choiceMultiple choice mode
SpeakingAnswer with voice
Speaking & ListeningPractice pronunciation
TypingTyping only mode
TOXICOLOGY - Leaderboard
TOXICOLOGY - Details
Levels:
Questions:
705 questions
🇬🇧 | 🇬🇧 |
1 First journal of experimental toxicology "__" in 1930 2 response to a tragic CONSEQUENCES OF ACUTE KIDNEY FAILURE after taking SULFANILAMIDE IN GLYCOL SOLUTIONS | 1 Archiv fur Toxicologie 2 Copeland Bill in U.S |
1 First journal of experimental toxicology "__" in 1930 2 response to a tragic CONSEQUENCES OF ACUTE KIDNEY FAILURE after taking SULFANILAMIDE IN GLYCOL SOLUTIONS | 1 Archiv fur Toxicologie 2 Copeland Bill in U.S |
1 First journal of experimental toxicology "__" in 1930 2 response to a tragic CONSEQUENCES OF ACUTE KIDNEY FAILURE after taking SULFANILAMIDE IN GLYCOL SOLUTIONS | 1 Archiv fur Toxicologie 2 Copeland Bill in U.S |
1 First journal of experimental toxicology "__" in 1930 2 response to a tragic CONSEQUENCES OF ACUTE KIDNEY FAILURE after taking SULFANILAMIDE IN GLYCOL SOLUTIONS | 1 Archiv fur Toxicologie 2 Copeland Bill in U.S |
ANTIQUITY 1 Included numerous references to POISONOUS PLANTS in his famous writing DE HISTORIA PLANTARUM 2 Added a number of poisons and clinical toxicology principles pertaining to BIOAVAILABILITY IN THERAPY and OVERDOSAGE | . 1 Theophrastus (370-286 BC) - Student of Aristotle 2 Hippocrates (400 BC) |
1 First journal of experimental toxicology "__" in 1930 2 response to a tragic CONSEQUENCES OF ACUTE KIDNEY FAILURE after taking SULFANILAMIDE IN GLYCOL SOLUTIONS | 1 Archiv fur Toxicologie 2 Copeland Bill in U.S |
1 First journal of experimental toxicology "__" in 1930 2 response to a tragic CONSEQUENCES OF ACUTE KIDNEY FAILURE after taking SULFANILAMIDE IN GLYCOL SOLUTIONS | 1 Archiv fur Toxicologie 2 Copeland Bill in U.S |
ANTIQUITY 1 The arrows of the Almighty are in me, my spirit drinks in their poison; God's terrors are marshaled against me. | 1 Book of Job (circa 1400 B.C) |
1 First journal of experimental toxicology "__" in 1930 2 response to a tragic CONSEQUENCES OF ACUTE KIDNEY FAILURE after taking SULFANILAMIDE IN GLYCOL SOLUTIONS | 1 Archiv fur Toxicologie 2 Copeland Bill in U.S |
MIDDLE AGES 1 DISSERTATION of treatment of poisoning of INSECTS, SNAKES, and Mad dogs Famous writings: TREATISE ON POISONS AND THEIR ANTIDOTES 2 Talks about the ONSET OF ACTION, POTENCY SITE OF ACTION, CLINICAL SIGNS & SYMPTOMS Tested toxic concoction | . 1 Maimonides (A.D 1135- 1204) 2 Catherine de Medici or Catherine de Mecici |
1 First journal of experimental toxicology "__" in 1930 2 response to a tragic CONSEQUENCES OF ACUTE KIDNEY FAILURE after taking SULFANILAMIDE IN GLYCOL SOLUTIONS | 1 Archiv fur Toxicologie 2 Copeland Bill in U.S |
(Describe the subject of bioavailability, noting that MILK, BUTTER and CREAM could DELAY INTESTINAL ABSORPTION. ) | TREATISE ON POISONS AND THEIR ANTIDOTES by Maimonides (A.D 1135-1204) |
1 First journal of experimental toxicology "__" in 1930 2 response to a tragic CONSEQUENCES OF ACUTE KIDNEY FAILURE after taking SULFANILAMIDE IN GLYCOL SOLUTIONS | 1 Archiv fur Toxicologie 2 Copeland Bill in U.S |
1 First journal of experimental toxicology "__" in 1930 2 response to a tragic CONSEQUENCES OF ACUTE KIDNEY FAILURE after taking SULFANILAMIDE IN GLYCOL SOLUTIONS | 1 Archiv fur Toxicologie 2 Copeland Bill in U.S |
Book by Paracelsus which IDENTIFY THE TOXICITY OF THE MERCURY and LEAD from GOLDSMITHING and AGRICOLA. Also the ETIOLOGY OF MINER’S DISEASE along with the treatment and prevention strategies. | On the Miner's Sickness and Other Diseases of Miners |
1 First journal of experimental toxicology "__" in 1930 2 response to a tragic CONSEQUENCES OF ACUTE KIDNEY FAILURE after taking SULFANILAMIDE IN GLYCOL SOLUTIONS | 1 Archiv fur Toxicologie 2 Copeland Bill in U.S |
Experimental toxicology accompanied the growth of organic chemistry | Age of Enlightenment- 19th century |
1 The discovered emetine is both __ 2 Causes DAMAGE IN SKELETAL MUSCLE and also in the cardiac tissue 3 DAMAGES THE HEART 4 (highly toxic crystalline alkaloid) It is colorless and bitter tasting and usually used as pesticides. | 1 myotoxic & cardiotoxic 2 MYOTOXIC 3 CARDIOTOXIC 4 Strychnine |
In this timeframe the discovery of radioactivity and vitamins, • Use of large bioassays, harmful to laboratory animals | 1890s and early 1900s |
1 First journal of experimental toxicology "__" in 1930 2 response to a tragic CONSEQUENCES OF ACUTE KIDNEY FAILURE after taking SULFANILAMIDE IN GLYCOL SOLUTIONS | 1 Archiv fur Toxicologie 2 Copeland Bill in U.S |
Concerned directly with toxicity testing Provide information for safety evaluation and also regulatory requirement o They are like part of the FDA | Descriptive toxicology |
Focused on the impact of different chemical pollutants on the environment especially in biological organisms | Environmental toxicology |
Classification of Toxic Agents | 1 Toxin 2 Toxicant |
Immunologically mediated adverse reaction to a chemical resulting from PREVIOUS SENSITIZATION to that chemical or to a structurally similar to a chemical that you are exposed to DOSE RELATED Repeated exposure that is structurally similar with the chemical that you are exposed to | Allergic Reactions hypersensitivity, allergic reaction, sensitization reaction |
1 o genetically determined abnormal reactivity to a chemical o NON DOSE RELATED 2 The response observed is usually qualitatively similar to that observed in all individuals. | 1 Idiosyncratic Reactions 2 Chemical idiosyncrasy |
1 Target organs in order of frequency of involvement in systemic toxicity are: 2 __ are seldom target tissues or systemic effects. | 1) 1 CNS 2 circulatory system; 3 the blood and hematopoietic system; 4 visceral organs such as the liver, kidney, and lung; and the 5 skin 2) muscles and bones |
Interaction of chemicals | 1 Additive effect 2 Synergistic effect 3 Potentiation 4 Antagonism |
4 TYPES OF ANTAGONISM | 1 Functional Antagonism 2 Chemical Antagonism / Inactivation 3 Dispositional Antagonism 4 Receptor Antagonism |
Two major mechanisms are RESPONSIBLE FOR TOLERANCE: | 1 due to a DECREASED AMOUNT OF TOXICANT REACHING THE SITE where the TOXIC EFFECT IS PRODUCED (dispositional tolerance) 2 due to a REDUCED RESPONSIVENESS of a TISSUE to the CHEMICAL |
CHARACTERISTICS OF EXPOSURE The major routes (pathways) by which toxic agents gain access to the body are: | 1 gastrointestinal tract (ingestion), 2 lungs(inhalation), 3 skin (topical, percutaneous, or dermal), 4 parenteral (other than intestinal canal) routes. |
CHARACTERISTICS OF EXPOSURE Descending order of effectiveness/can give toxic effects: | 1) IV, 2 Inhalational, 3 Intraperitoneal, 4 Subcutaneous, 5 Intramuscular, 6 intradermal, 7 oral and 8 dermal unless broken |
Repeated exposure is divided into three categories: | 1 subacute, 2 subchronic, and 3 chronic. |
Dose-Response Two Types | 1 Individual, or Graded Dose-Response Relationship 2 Quantal Dose-Response Relationship-Normal or Gaussian Distribution |
§ Population is classified as either a “responder” or a “nonresponder.” § LD50 - means you are trying to look on the 50% died on animal tested by giving a single dose of the substance then it is expected to death in 50% of the animal tested | Quantal Dose-Response Relationship-Normal or Gaussian Distribution |
1 animals that RESPOND AT LOWER DOSE 2 Animals that DIED AT HIGHER DOSE | 1 HYPERSUSCEPTIBLE 2 RESISTANT |
2. Quantal Dose-Response Relationships: sigmoid dose-response curve 1) +-1 SD = __ population (%) 2) +-2 SD = __ population (%) 3) +-3 SD = __ population (%) | . 1) 68.3% 2) 96.5% 3) 99.7% |
RATIO of the DOSE REQUIRED TO PRODUCE TOXIC EFFECT and dose needed to ELICIT THE DESIRED THERAPEUTIC RESPONSE | Therapeutic Index = : TD50/ED50 |
1 The LARGER the ratio between the TD50 and ED50, the __ the RELATIVE SAFETY of the drug or tested substance | Greater larger ratio td50 & ed50 = MORE SAFE |
Variations in Toxic Responses: | 1 Selective Toxicity 2 Species Differences 3 Individual Differences in response |
O Due to GENETIC DIFFERENCES THAT HAS NO SIDE EFFECTS o GENETIC POLYMORPHISM o Idiosyncratic | Individual Differences in response |
1 When a toxicant is delivered intended target, it reacts with it and causes 1 __ which leads to 2 __ 2 Sometimes, the toxicant will not reach its target molecule but rather it can adversely influence the __, causing __ | 1) 1 cellular dysfunction 2 toxicity 2) 1 biological environment 2 molecular, organellar, cellular, or organ dysfunction leading to deleterious effects. So its much worse if a toxicant does not reach the target site |
Mechanism of Toxicity STEPS | Step 1 - Delivery - Delivery of toxicant to its target molecule. Step 2 - Either INTERACT w/ MOLECULES or ALTER ENVIRONMENT Step 3 - Trigger perturbation in cell function/structure - changing the normal state of cell function in other molecules. Step 4 - Initiate repair - Body initiate repair mechanisms at cellular/ tissue level - If beyond repair, toxicity occurs DIAI (DIAY) |
(STEP 1 --- DELIVERY: FROM THE SITE OF EXPOSURE TO THE TARGET) 1 Theoretically, the ultimate toxicant's concentration and persistence at the site of action determine __ 2 The CONCENTRATION of the ULTIMATE TOXICANT at the target molecule depends on the __ | . 1 how STRONG/INTENSE a toxic effect will be. 2 relative effectiveness of the PROCESSES that INCREASE or DECREASE ITS CONCENTRATION at the target site |
(STEP 1 --- DELIVERY: FROM THE SITE OF EXPOSURE TO THE TARGET) ULTIMATE TOXICANT 1 Its INCREASED CONCENTRATION is facilitated by __ 2 DECREASED CONCENTRATION is facilitated by __ | . 1 - Absorption, - Distribution to the site of action, - Reabsorption, and - Toxication ADR T 2 - Presystemic elimination, - Distribution away from the site of action, - Excretion, and - Detoxication. PDED |
A. ABSORPTION VS PRESYSTEMIC ELIMINATION 1 is the process by which a CHEMICAL IS TRANSFERRED FROM THE SITE OF EXPOSURE, usually an internal or external body surface, INTO the SYSTEMIC CIRCULATION. 2 Factors that influence this: | 1 Absorption 2 Concentration Surface area of exposure Characteristics of the epithelial layer through which the toxicant is being absorbed lipid solubility (MOST IMPORTANT) |
B. DISTRIBUTION TO AND AWAY FROM THE TARGET 1 Mechanisms facilitating DISTRIBUTION TO A TARGET | 1) Porosity of the Capillary Endothelium 2) Specialized Transport Across the Membrane 3) Accumulation in Cell Organelles 4) Reversible Intracellular Binding PaSAR (naka PaSAR) |
(Mechanisms facilitating DISTRIBUTION TO A TARGET) - Porosity of the Capillary Endothelium Endothelial cells in the hepatic sinusoids and in the renal peritubular capillaries have __ which has a diameter of __ that permit passage of even __ | 1 large fenestrae (opening) 2 (50 to 150 nm in diameter) 3 protein bound xenobiotics |
(Mechanisms facilitating DISTRIBUTION TO A TARGET) - Specialized Transport Across the Membrane 1 __ can contribute to the delivery of toxicants to intracellular targets. 2 __ FACILITATE the ENTRY of TOXICANTS into specific cells, rendering those cells targets. 3 The __ of some TOXICANT– PROTEIN COMPLEXES occurs in some cells as well. | . 1 Specialized ion channels and Membrane transporters 2) 1 Na+ & K+ ATPase, 2 Voltagegated Ca2+ channels, 3 Carrier-mediated uptake, 4 Endocytosis, and 5 Membrane recycling 3) Endocytosis |
(Mechanisms facilitating DISTRIBUTION TO A TARGET) - Reversible Intracellular Binding 1 Chemicals that BIND to MELANIN, such as __ accumulate in cells that contain melanin | . 1 organic and inorganic cations 2 polycyclic aromatic hydrocarbons |
B. DISTRIBUTION TO AND AWAY FROM THE TARGET 1 Mechanisms OPPOSING DISTRIBUTION TO A TARGET | 1) Binding to Plasma Proteins 2 Specialized Barriers 3 Distribution to Storage Sites 4 Association with Intracellular Binding Proteins 5 Export from Cells |
(Mechanisms OPPOSING DISTRIBUTION TO A TARGET) - Specialized Barriers 1 Because brain capillaries LACK __ and have extremely tight junctions, substances that are __ CANNOT ENTER THE BRAIN except by __ 2 The spermatogenic cells are surrounded by __ that are tightly joined to form the __. 3 Transfer of HYDROPHILIC TOXICANTS across the placenta is RESTRICTED. However, NONE of these BARRIERS are EFFECTIVE AGAINST __ | . 1) 1 fenestrae 2 hydrophilic, 3 active transport 2) 1 Sertoli cells, 2 blood–testis barrier 3 lipophilic substances. Hydrophilic = Restricted Lipophilic = Not Restricted |